• Home
  • Pharmacy Medical Policy Updates - Correction

Pharmacy Medical Policy Updates - Correction

It has been brought to our attention that some of the links were incorrect in the Pharmacy Medical Policy Updates sent on 5/2/22. Below are the corrected links.

Effective  June 1, 2022:

  • Site of Care Infusion Management
  • IL-5 Inhibitors
  • Xolair
  • Opioids ER
  • ATTR Amyloidosis
  • ATTR Amyloidosis – Onpattro
  • DPP-4 Inhibitors
  • Rapid to Intermediate Acting Insulin

Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.

To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page of our website, https://www.bcbsks.com/providers/precertification-prior-authorization

We apologize for any inconvenience this may has caused. If you have any questions regarding this newsletter, please contact your BCBSKS provider representative/consultant.

Institutional Providers
Professional Providers